Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

B.C. to provide fourth dose of COVID-19 vaccine for people age 70+

Provincial health officer Dr. Bonnie Henry said Tuesday it is likely the province will see an increase in COVID cases in the next few months as restrictions are lifted. As a result, all long-term care residents, anyone over 70 years old and Indigenous people aged 55 and over will be receiving a fourth dose of the COVID vaccine six months after their third – Apr 5, 2022

Clinically extremely vulnerable British Columbians and those 70 years of age and older will have access to a fourth dose of a COVID-19 vaccine six months after their third vaccine.

Story continues below advertisement

The province announced Tuesday it will start by providing the shot for those living in long-term care and those who are clinically extremely vulnerable.

“Our intent is to provide this extra boost to increase antibodies and also reinforce the immunity to protect from severe illness and death,” Henry said.

“People will be receiving their invitation in the coming week.”

The priority list will also include Indigenous British Columbians 55 years of age and older.

Story continues below advertisement

The invitations to book a booster shot will be provided through the province’s ongoing immunization program.

The National Advisory Committee on Immunization announced on Tuesday Canada should prepare for “the rapid deployment” of a second COVID-19 booster program over the coming weeks prioritizing adults 80 and over and residents of long-term care or other congregate settings.

There has been no guidance provided to when those under the age of 70 who live in the community should be offered a fourth COVID shot.

There has been a recent uptick in COVID-19 hospitalizations in B.C. for those 80 years and older.

Story continues below advertisement

From January 2022 to March 2022, hospitalizations for the unvaccinated were 400 per 100,000 people. The rate of hospitalization for those with two doses was 160 per 100,000 while it was around 60 per 100,000 for those with three doses.

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article